Filing Flows

Filing Flows › Companies › Bruker › Cash flow

Bruker cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow$96.7M in Q3 2026 · $245M over twelve months

Operating cash flow$118M
Capital spending−$21.5M
Free cash flow+$96.7M
Cash conversion cycle246 days

Analysis

In Q3 2026, Bruker generated $118M of operating cash flow and spent $21.5M on capital projects, leaving free cash flow of $96.7M. That is $151M more than in Q3 2025 (−$54.1M).

Over the twelve months to Sep 30, 2026, operating cash flow was $342M; the largest uses were net borrowing (+) / repaid (−) ($216M), capital spending ($97.1M), other financing ($87.2M); the cash balance fell by $174M.

Operating cash flow was $118M against net income of −$110M. The largest differences: impairments +$211M, deferred taxes −$58.4M, depreciation & amortization +$54.1M.

Its cash conversion cycle was 246 days (receivables 58 + inventory 230 − payables 42).

Free cash flow

Bruker: free cash flow by quarterBruker: free cash flow by quarter$153MQ4 2024$39.0MQ1 2025−$149MQ2 2025−$54.1MQ3 2025$207MQ4 2025$47.0MQ1 2026−$106MQ2 2026$96.7MQ3 2026
Operating cash flow less capital spending.
Bruker: operating cash flow against capital spendingBruker: operating cash flow against capital spendingOperating cash flowCapital spending$190M$36.7MQ4 2024$65.0M$26.0MQ1 2025−$128M$21.3MQ2 2025−$33.2M$20.9MQ3 2025$230M$22.6MQ4 2025$71.2M$24.2MQ1 2026−$77.4M$28.8MQ2 2026$118M$21.5MQ3 2026
Latest (Q3 2026): Operating cash flow $118M, Capital spending $21.5M.

Capital allocation, year by year

Bruker: where the cash came from (up) and went (down), by fiscal yearBruker: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingAcquisitionsBuybacksDividendsFY2021: Operating cash flow $282MFY2021: Net borrowing $489MFY2021: Shares issued $7.0MFY2021: Asset sales $4.9MFY2021: Capital spending −$92.0MFY2021: Acquisitions −$65.0MFY2021: Buybacks −$153MFY2021: Dividends −$24.2M$783MFY2021FY2022: Operating cash flow $274MFY2022: Net borrowing $300KFY2022: Shares issued $2.8MFY2022: Asset sales $13.9MFY2022: Capital spending −$129MFY2022: Acquisitions −$182MFY2022: Buybacks −$263MFY2022: Dividends −$29.8M$291MFY2022FY2023: Operating cash flow $350MFY2023: Net borrowing −$30.0MFY2023: Shares issued $9.5MFY2023: Asset sales $11.1MFY2023: Capital spending −$107MFY2023: Acquisitions −$227MFY2023: Buybacks −$152MFY2023: Dividends −$29.4M$371MFY2023FY2024: Operating cash flow $251MFY2024: Net borrowing $870MFY2024: Shares issued $409MFY2024: Asset sales $1.1MFY2024: Capital spending −$115MFY2024: Acquisitions −$1.6BFY2024: Dividends −$30.2M$1.5BFY2024FY2025: Operating cash flow $134MFY2025: Net borrowing −$497MFY2025: Shares issued $7.9MFY2025: Capital spending −$90.8MFY2025: Acquisitions −$73.9MFY2025: Buybacks −$10.0MFY2025: Dividends −$22.8M$142MFY2025
Over these 5 years operating cash flow totalled $1.3B; the largest uses were acquisitions ($2.1B) and buybacks ($579M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$120M
Debt$1.7B
Net debt$1.6B
Due within a year$11.9M

Bruker funds itself: free cash flow was $245M over the last twelve months, and $120M of cash and investments stands against $1.7B of debt ($11.9M due within a year, 10.1× covered by cash).

Bruker: debt maturities by year (FY2025)Bruker: debt maturities by year (FY2025)$11.9MYear 1$19.3MYear 2$20.4MYear 3$539MYear 4$10.9MYear 5$1.3BAfter year 5
Principal due in each year as disclosed in the annual report, against $120M of cash and investments now.

Where the cash came from and went

Bruker: sources (+) and uses (−) of cash, Q3 2026Bruker: sources (+) and uses (−) of cash, Q3 2026Operating cash flow$118MCash drawn (+) / kept (−)$65.3MNet borrowing (+) / repaid (−)−$57.7MAcquisitions−$57.0MOther financing−$44.7MCapital spending−$21.5MDividends−$7.7MOther investing$5.8MExchange rates−$700K
Bruker: sources (+) and uses (−) of cash, TTM to Q3 2026Bruker: sources (+) and uses (−) of cash, TTM to Q3 2026Operating cash flow$342MNet borrowing (+) / repaid (−)−$216MCash drawn (+) / kept (−)$174MCapital spending−$97.1MOther financing−$87.2MAcquisitions−$77.2MDividends−$30.3MOther investing−$18.9MExchange rates$11.3M

From profit to cash

Bruker: net income to operating cash flow, Q3 2026Bruker: net income to operating cash flow, Q3 2026Net income−$110MDepreciation & amortization$54.1MStock-based pay$6.1MDeferred taxes−$58.4MImpairments$211MOther non-cash$31.9MInventory−$4.9MPayables$11.8MIncome taxes payable−$6.6MOther operating capital−$13.6MOperating cash flow$118M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 20265823042246
Q2 20265924151250
Q1 20265922549235
Q4 20255220035216
Q3 20255723141247
Q2 20256124250252
Q1 20256224053249
Q4 20245221644225

Every quarter

QuarterOperating cash flowCapital spendingAcquisitionsBuybacksDividendsNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026$118M−$21.5M−$57.0M—−$7.7M−$57.7M—$65.3M$96.7M
Q2 2026−$77.4M−$28.8M——−$7.5M$168M—−$51.5M−$106M
Q1 2026$71.2M−$24.2M−$16.0M—−$7.6M−$181M—$166M$47.0M
Q4 2025$230M−$22.6M−$4.2M—−$7.5M−$160M$3.8M−$5.8M$207M
Q3 2025−$33.2M−$20.9M−$200K——−$416M−$1.2M−$201M−$54.1M
Q2 2025−$128M−$21.3M−$68.4M—−$7.6M$102M$4.9M$91.5M−$149M
Q1 2025$65.0M−$26.0M−$1.1M−$10.0M−$7.7M−$32.8M$400K−$1.0M$39.0M
Q4 2024$190M−$36.7M−$22.9M—−$7.6M$914M$406M−$35.0M$153M

Bruker: income statement and cash flow

Bruker, Q3 2026: revenue $874M (+2% year over year), operating margin -10.4%. The chart follows the revenue to costs, profit and cash.

Bruker: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.